DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines.
DIANT Pharma has raised $292K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in May 2025.
DIANT Pharma's investors include National Science Foundation.
DIANT Pharma is headquartered in Storrs Mansfield, United States.
DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines.
DIANT Pharma is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DIANT Pharma — Funding & Investors." VCBacked, May 1, 2025, https://www.vcbacked.co/company/diant-pharma. Accessed August 14, 2026.
VCBacked. (2025). DIANT Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/diant-pharma
{{cite web |title=DIANT Pharma — Funding & Investors |url=https://www.vcbacked.co/company/diant-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated